Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
S Fletcher, MI Bellgard, L Price, AP Akkari & SD Wilton. (2017) Translational development of splice-modifying antisense oligomers. Expert Opinion on Biological Therapy 17:1, pages 15-30.
Read now
Read now
Bo Bao & Toshifumi Yokota. (2015) Potential of antisense therapy for facioscapulohumeral muscular dystrophy. Expert Opinion on Orphan Drugs 3:12, pages 1365-1374.
Read now
Read now
Articles from other publishers (50)
James S. Novak, Rita Spathis, Utkarsh J. Dang, Alyson A. Fiorillo, Ravi Hindupur, Christopher B. Tully, Davi A.G. Mázala, Emily Canessa, Kristy J. Brown, Terence A. Partridge, Yetrib Hathout & Kanneboyina Nagaraju. (2021) Interrogation of Dystrophin and Dystroglycan Complex Protein Turnover After Exon Skipping Therapy. Journal of Neuromuscular Diseases 8:s2, pages S383-S402.
Crossref
Crossref
Kajal Biswas, Martin Couillard, Luca Cavallone, Sandra Burkett, Stacey Stauffer, Betty K. Martin, Eileen Southon, Susan Reid, Teri M. Plona, Ryan N. Baugher, Stephanie D. Mellott, Kristen M. Pike, Mary E. Albaugh, Chelsea Maedler-Kron, Nancy Hamel, Lino Tessarollo, Victoria Marcus, William D. Foulkes & Shyam K. Sharan. (2021) A novel mouse model of PMS2 founder mutation that causes mismatch repair defect due to aberrant splicing. Cell Death & Disease 12:9.
Crossref
Crossref
Kiran Musunuru, Ray E. Hershberger, Sharlene M. Day, N. Jennifer Klinedinst, Andrew P. Landstrom, Victoria N. Parikh, Siddharth Prakash, Christopher Semsarian & Amy C. Sturm. (2020) Genetic Testing for Inherited Cardiovascular Diseases: A Scientific Statement From the American Heart Association. Circulation: Genomic and Precision Medicine 13:4.
Crossref
Crossref
Emily M. Mills, Victoria L. Barlow, Louis Y. P. Luk & Yu-Hsuan Tsai. (2019) Applying switchable Cas9 variants to in vivo gene editing for therapeutic applications. Cell Biology and Toxicology 36:1, pages 17-29.
Crossref
Crossref
Shouta Miyatake, Yoshitaka Mizobe, Maria K. Tsoumpra, Kenji Rowel Q. Lim, Yuko Hara, Fazel Shabanpoor, Toshifumi Yokota, Shin’ichi Takeda & Yoshitsugu Aoki. (2019) Scavenger Receptor Class A1 Mediates Uptake of Morpholino Antisense Oligonucleotide into Dystrophic Skeletal Muscle. Molecular Therapy - Nucleic Acids 14, pages 520-535.
Crossref
Crossref
Takenori Shimo, Keisuke Tachibana & Satoshi Obika. (2018) Construction of a tri-chromatic reporter cell line for the rapid and simple screening of splice-switching oligonucleotides targeting DMD exon 51 using high content screening. PLOS ONE 13:5, pages e0197373.
Crossref
Crossref
Chuan Xu, Jiajun Chen, Yingyu Zhang & Jia Li. (2018) Limb-girdle muscular dystrophy type 2B misdiagnosed as polymyositis at the early stage. Medicine 97:21, pages e10539.
Crossref
Crossref
David J. Coote, Mark R. Davis, Macarena Cabrera, Merrilee Needham, Nigel G. Laing & Kristen J. Nowak. (2018) CUGC for Duchenne muscular dystrophy (DMD). European Journal of Human Genetics 26:5, pages 749-757.
Crossref
Crossref
Sean Porazinski & Michael Ladomery. (2018) Alternative Splicing in the Hippo Pathway—Implications for Disease and Potential Therapeutic Targets. Genes 9:3, pages 161.
Crossref
Crossref
Tejal Aslesh, Rika Maruyama & Toshifumi Yokota. (2018) Skipping Multiple Exons to Treat DMD—Promises and Challenges. Biomedicines 6:1, pages 1.
Crossref
Crossref
Tanya Bardakjian & Pedro Gonzalez-Alegre. 2018. Neurogenetics, Part I. Neurogenetics, Part I
93
102
.
Yandi Gao, Li Xu & Renzhi Han. 2018. Gene Therapy in Neurological Disorders. Gene Therapy in Neurological Disorders
277
285
.
Rika Maruyama & Toshifumi Yokota. 2018. Exon Skipping and Inclusion Therapies. Exon Skipping and Inclusion Therapies
79
90
.
Kara Goodkey, Tejal Aslesh, Rika Maruyama & Toshifumi Yokota. 2018. Exon Skipping and Inclusion Therapies. Exon Skipping and Inclusion Therapies
69
76
.
Hae-Won Son & Toshifumi Yokota. 2018. Exon Skipping and Inclusion Therapies. Exon Skipping and Inclusion Therapies
57
68
.
Tejal Aslesh, Rika Maruyama & Toshifumi Yokota. 2018. Exon Skipping and Inclusion Therapies. Exon Skipping and Inclusion Therapies
455
465
.
Aleksander Touznik, Rika Maruyama & Toshifumi Yokota. 2018. Exon Skipping and Inclusion Therapies. Exon Skipping and Inclusion Therapies
439
454
.
Rika Maruyama, Yoshitsugu Aoki, Shin’ichi Takeda & Toshifumi Yokota. 2018. Exon Skipping and Inclusion Therapies. Exon Skipping and Inclusion Therapies
365
379
.
Yoshitaka Mizobe, Shouta Miyatake, Hotake Takizawa, Yuko Hara, Toshifumi Yokota, Akinori Nakamura, Shin’Ichi Takeda & Yoshitsugu Aoki. 2018. Exon Skipping and Inclusion Therapies. Exon Skipping and Inclusion Therapies
275
292
.
Shouta Miyatake, Yoshitaka Mizobe, Hotake Takizawa, Yuko Hara, Toshifumi Yokota, Shin’ichi Takeda & Yoshitsugu Aoki. 2018. Duchenne Muscular Dystrophy. Duchenne Muscular Dystrophy
123
141
.
Takenori Shimo, Rika Maruyama & Toshifumi Yokota. 2018. Duchenne Muscular Dystrophy. Duchenne Muscular Dystrophy
143
155
.
Rachel Z. BlumhagenBrenna R. HedinKenneth C. MalcolmEllen L. BurnhamMarc MossEdward AbrahamTristan J. HuieJerry A. NickTasha E. FingerlinScott Alper. (2017) Alternative pre-mRNA splicing of Toll-like receptor signaling components in peripheral blood mononuclear cells from patients with ARDS. American Journal of Physiology-Lung Cellular and Molecular Physiology 313:5, pages L930-L939.
Crossref
Crossref
Quynh Nguyen & Toshifumi Yokota. (2017) Immortalized Muscle Cell Model to Test the Exon Skipping Efficacy for Duchenne Muscular Dystrophy. Journal of Personalized Medicine 7:4, pages 13.
Crossref
Crossref
James S. Novak, Marshall W. Hogarth, Jessica F. Boehler, Marie Nearing, Maria C. Vila, Raul Heredia, Alyson A. Fiorillo, Aiping Zhang, Yetrib Hathout, Eric P. Hoffman, Jyoti K. Jaiswal, Kanneboyina Nagaraju, Sebahattin Cirak & Terence A. Partridge. (2017) Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle. Nature Communications 8:1.
Crossref
Crossref
Lucy Norcliffe-Kaufmann, Susan A. Slaugenhaupt & Horacio Kaufmann. (2017) Familial dysautonomia: History, genotype, phenotype and translational research. Progress in Neurobiology 152, pages 131-148.
Crossref
Crossref
Ulrike Bonati, Štefan Holiga, Nicole Hellbach, Céline Risterucci, Tobias Bergauer, Wakana Tang, Patricia Hafner, Alain Thoeni, Oliver Bieri, Irene Gerlach, Anne Marquet, Omar Khwaja, Fabio Sambataro, Alessandro Bertolino, Juergen Dukart, Arne Fischmann, Dirk Fischer & Christian Czech. (2017) Longitudinal characterization of biomarkers for spinal muscular atrophy. Annals of Clinical and Translational Neurology 4:5, pages 292-304.
Crossref
Crossref
Wenqing Fu, Alessio Ligabue, Kai J. Rogers, Joshua M. Akey & Raymond J. MonnatJr.Jr.. (2017)
Human
RECQ
Helicase Pathogenic Variants, Population Variation and “Missing” Diseases
. Human Mutation 38:2, pages 193-203.
Crossref
Crossref
John Rendu, Rodrick Montjean, Charles Coutton, Mohnish Suri, Gaetan Chicanne, Anne Petiot, Julie Brocard, Didier Grunwald, France Pietri Rouxel, Bernard Payrastre, Joel Lunardi, Olivier Dorseuil, Isabelle Marty & Julien Fauré. (2017)
Functional Characterization and Rescue of a Deep Intronic Mutation in
OCRL
Gene Responsible for Lowe Syndrome
. Human Mutation 38:2, pages 152-159.
Crossref
Crossref
Rika Maruyama, Yusuke Echigoya, Oana Caluseriu, Yoshitsugu Aoki, Shin’ichi Takeda & Toshifumi Yokota. 2017. Morpholino Oligomers. Morpholino Oligomers
201
213
.
Glenn CruseYuzhi YinTomoki FukuyamaAvanti DesaiGreer K. ArthurWolfgang BäumerMichael A. Beaven & Dean D. Metcalfe. (2016) Exon skipping of FcεRIβ eliminates expression of the high-affinity IgE receptor in mast cells with therapeutic potential for allergy. Proceedings of the National Academy of Sciences 113:49, pages 14115-14120.
Crossref
Crossref
Yuri Kitamura, Eri Kondo, Mari Urano, Ryoko Aoki & Kayoko Saito. (2016) Target resequencing of neuromuscular disease-related genes using next-generation sequencing for patients with undiagnosed early-onset neuromuscular disorders. Journal of Human Genetics 61:11, pages 931-942.
Crossref
Crossref
Gregory P. Holmes-Hampton, Daniel R. Crooks, Ronald G. Haller, Shuling Guo, Susan M. Freier, Brett P. Monia & Tracey A. Rouault. (2016) Use of antisense oligonucleotides to correct the splicing error in ISCU myopathy patient cell lines. Human Molecular Genetics, pages ddw338.
Crossref
Crossref
Seema Mital, Kiran Musunuru, Vidu Garg, Mark W. Russell, David E. Lanfear, Rajat M. Gupta, Kathleen T. Hickey, Michael J. Ackerman, Marco V. Perez, Dan M. Roden, Daniel Woo, Caroline S. Fox & Stephanie Ware. (2016) Enhancing Literacy in Cardiovascular Genetics: A Scientific Statement From the American Heart Association. Circulation: Cardiovascular Genetics 9:5, pages 448-467.
Crossref
Crossref
Jacqueline N. Robinson-Hamm & Charles A. Gersbach. (2016) Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy. Human Genetics 135:9, pages 1029-1040.
Crossref
Crossref
Pierre G. Carlier, Benjamin Marty, Olivier Scheidegger, Paulo Loureiro de Sousa, Pierre-Yves Baudin, Eduard Snezhko & Dmitry Vlodavets. (2016) Imagerie et spectroscopie par résonance magnétique nucléaire du muscle strié squelettique. Les Cahiers de Myologie:13, pages 34-67.
Crossref
Crossref
Christopher S. Rogers. (2016) Genetically engineered livestock for biomedical models. Transgenic Research 25:3, pages 345-359.
Crossref
Crossref
Pierre G. Carlier, Benjamin Marty, Olivier Scheidegger, Paulo Loureiro de Sousa, Pierre-Yves Baudin, Eduard Snezhko & Dmitry Vlodavets. (2016) Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials. Journal of Neuromuscular Diseases 3:1, pages 1-28.
Crossref
Crossref
Merryl Rodrigues, Yusuke Echigoya, So-ichiro Fukada & Toshifumi Yokota. (2016) Current Translational Research and Murine Models For Duchenne Muscular Dystrophy. Journal of Neuromuscular Diseases 3:1, pages 29-48.
Crossref
Crossref
Mary H. Wertz & Mustafa Sahin. (2016) Developing therapies for spinal muscular atrophy. Annals of the New York Academy of Sciences 1366:1, pages 5-19.
Crossref
Crossref
Susana Igreja, Luka A. Clarke, Hugo M. Botelho, Luís Marques & Margarida D. Amaral. (2016) Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides. Human Mutation 37:2, pages 209-215.
Crossref
Crossref
Bo Bao, Rika Maruyama & Toshifumi Yokota. (2016) Targeting mRNA for the treatment of facioscapulohumeral muscular dystrophy. Intractable & Rare Diseases Research 5:3, pages 168-176.
Crossref
Crossref
Joshua J. A. Lee & Toshifumi Yokota. 2016. Translational Research in Muscular Dystrophy. Translational Research in Muscular Dystrophy
87
102
.
Christian Czech, Wakana Tang, Teodorica Bugawan, Calvin Mano, Carsten Horn, Victor Alejandro Iglesias, Stefanie Fröhner, Phillip G. Zaworski, Sergey Paushkin, Karen Chen & Thomas Kremer. (2015) Biomarker for Spinal Muscular Atrophy: Expression of SMN in Peripheral Blood of SMA Patients and Healthy Controls. PLOS ONE 10:10, pages e0139950.
Crossref
Crossref
Ashley Guncay & Toshifumi Yokota. (2015) Antisense oligonucleotide drugs for Duchenne muscular dystrophy: how far have we come and what does the future hold?. Future Medicinal Chemistry 7:13, pages 1631-1635.
Crossref
Crossref
Bailey Nichols, Shin'ichi Takeda & Toshifumi Yokota. (2015) Nonmechanical Roles of Dystrophin and Associated Proteins in Exercise, Neuromuscular Junctions, and Brains. Brain Sciences 5:3, pages 275-298.
Crossref
Crossref
Dorota Sienkiewicz, Wojciech Kulak, Bożena Okurowska-Zawada, Grażyna Paszko-Patej & Katarzyna Kawnik. (2015) Duchenne muscular dystrophy: current cell therapies. Therapeutic Advances in Neurological Disorders 8:4, pages 166-177.
Crossref
Crossref
Mirjam Ketema, Pablo Secades, Maaike Kreft, Leila Nahidiazar, Hans Janssen, Kees Jalink, Jose M. de Pereda & Arnoud Sonnenberg. (2015) The rod domain is not essential for the function of plectin in maintaining tissue integrity. Molecular Biology of the Cell 26:13, pages 2402-2417.
Crossref
Crossref
Nicolas Wein, Lindsay Alfano & Kevin M. Flanigan. (2015) Genetics and Emerging Treatments for Duchenne and Becker Muscular Dystrophy. Pediatric Clinics of North America 62:3, pages 723-742.
Crossref
Crossref
Yusuke Echigoya, Vincent Mouly, Luis Garcia, Toshifumi Yokota & William Duddy. (2015) In Silico Screening Based on Predictive Algorithms as a Design Tool for Exon Skipping Oligonucleotides in Duchenne Muscular Dystrophy. PLOS ONE 10:3, pages e0120058.
Crossref
Crossref
Casey A. Maguire, Servio H. Ramirez, Steven F. Merkel, Miguel Sena-Esteves & Xandra O. Breakefield. (2014) Gene Therapy for the Nervous System: Challenges and New Strategies. Neurotherapeutics 11:4, pages 817-839.
Crossref
Crossref